NovaGo Therapeutics AG

Swiss Biotech Association

Member

NovaGo Therapeutics is a biotech start-up company dedicated to the development of human antibody therapeutics that promotes nerve repair and regeneration in the treatment of cerebral stroke and spinal cord injury by targeting Nogo-A. Nogo-A is the most potent inhibitor of nerve fiber regeneration.

http://www.novagotherapeutics.com

Location

Wagistrasse 27, 8952 Schlieren, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2015
Number of employees in Switzerland

1-9

Key business

Core competencies

Therapeutics/vaccines (human)

You may also be interested in

Laevoroc Oncology AG

Founded in 2019, Laevoroc is a privately-owned, Swiss oncology group of companies that leverages word-class technologies, our oncology expertise and extensive R&D and commercial experience to approach innovation in cancer therapeutics in a way that combines the pragmatic with the visionary.
Hünenberg

Member

Rowestil Consulting GmbH

Expertise in exploratory clinical drug/diagnostic development is available across a number of disease areas. Timing of input into the developmental strategy from regulatory and commercial perspectives is important in moving development programs towards success.
6318 Walchwil

Member

Sintetica SA

Sintetica is a pharmaceutical company delivering injectable medicines to patients worldwide, through innovative science and excellence in development, production and marketing. The multicultural high-performing organization is built to support both the national growth and the global expansion.
6850 Mendrisio

Member